Mumbai, Aug 10 (UNI) Pharma major, Everest Organics on Monday said that Remdesivir API has been successfully developed in the R & D facility of the company.

Commenting on the R&D success of EOL team, Dr. Sirisha Srikakarlapudi, Director, EOL - New Product Development said, "lt's a moment of utmost satisfaction that with hard work of the past few months by Everest Organics R&D team, we have been able to successfully develop Remdesivir API at lab scale in short span of time.'

'The development of Remdesivir API by Everest Organics Limited is the outcome of investments we've made in R&D over the period of the last few years, which further helped strengthening technical expertise. Infact we are poised for development of more products in the Anti-Viral segments in the future"Mr Srikakarlapudi added.

UNI JS NV RHK1346